TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Skin Cancer Diagnostics Market – By Type
1.3.2 Global Skin Cancer Diagnostics Market – By Screening Type
1.3.3 Global Skin Cancer Diagnostics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Skin Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa– PEST Analysis
4.2.5 South and Central America– PEST Analysis
4.3 Expert Opinion
5. Skin Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Skin Cancer
5.1.2 Launch of New Products
5.2 Market Restraints
5.2.1 Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries
5.3 Market Opportunities
5.3.1 Government Support for Early Skin Cancer Diagnosis
5.4 Future Trends
5.4.1 Skin Cancer Diagnostics Through AI
5.5 Impact Analysis
6. Skin Cancer Diagnostics Market – Global Analysis
6.1 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Skin Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Melanoma
7.3.1 Overview
7.3.2 Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Non-melanoma
7.4.1 Overview
7.4.2 Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Skin Cancer Diagnostics Market – By Screening Type
8.1 Overview
8.2 Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)
8.3 Blood Tests
8.3.1 Overview
8.3.2 Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Dermatoscopy
8.4.1 Overview
8.4.2 Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Imaging Tests
8.5.1 Overview
8.5.2 Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Lymph Node Biopsy
8.6.1 Overview
8.6.2 Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Skin Biopsy
8.7.1 Overview
8.7.2 Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Skin Cancer Diagnostics Market – Regional Analysis
9.1 North America: Skin Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.3 North America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.1.4 North America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)
9.1.5 North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.1.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.1.2 US: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.1.5.1.3 US: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.1.5.2 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.2.1 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.2.2 Canada: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.1.5.2.3 Canada: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.1.5.3 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.3.1 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.5.3.2 Mexico: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.1.5.3.3 Mexico: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.2 Europe: Skin Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.4 Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5 Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.1.4 Germany: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 United Kingdom: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.2.4 United Kingdom: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.3 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.3.4 France: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.4 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.4.4 Italy: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.5 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.5.4 Spain: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.6 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3 Asia Pacific Skin Cancer Diagnostics Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.4 Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5 Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
9.3.5.1.3 China: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.1.4 China: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.2.4 Japan: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5.3 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.3.4 India: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5.4 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 South Korea: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.4.4 South Korea: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5.5 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 Australia: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.5.4 Australia: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.3.5.6 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.3.5.6.4 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.4 Middle East and Africa: Skin Cancer Diagnostics Market
9.4.1 Overview
9.4.2 Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.3 Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.4.4 Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)
9.4.5 Middle East and Africa: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.4.5.1 UAE: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.1.1 UAE: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.1.2 UAE: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.4.5.1.3 UAE: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.4.5.2 Saudi Arabia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.2.1 Saudi Arabia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.2.2 Saudi Arabia: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.4.5.2.3 Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.4.5.3 South Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.3.1 South Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.3.2 South Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.4.5.3.3 South Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.4.5.4 Rest of Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.4.1 Rest of Middle East and Africa: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.4.5.4.2 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.4.5.4.3 Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.5 South and Central America: Skin Cancer Diagnostics Market
9.5.1 Overview
9.5.2 South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.3 South and Central America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.5.4 South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)
9.5.5 South and Central America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.1.1 Brazil: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.1.2 Brazil: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.5.5.1.3 Brazil: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.5.5.2 Argentina: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.2.1 Argentina: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.2.2 Argentina: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.5.5.2.3 Argentina: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
9.5.5.3 Rest of South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.3.1 Rest of South and Central America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.5.5.3.2 Rest of South and Central America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
9.5.5.3.3 Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ‘Million)
10. Impact of COVID-19 Pandemic on Global Skin Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Skin Cancer Diagnostic Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Skin Cancer Diagnostic Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 SkylineDx BV
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 SWOT Analysis
12.1.5 Key Developments
12.2 AMLo Biosciences Limited
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 NeraCare GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 DermLite LLC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 bioMerieux SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Veriskin Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Castle Biosciences, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DermTech Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 HOFFMANN-LA ROCHE LTD.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 Michelson Diagnostics Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. US: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Canada: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Canada: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Mexico: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Mexico: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 13. United Kingdom Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. United Kingdom Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. France Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 23. Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 25. China Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. China Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 27. Japan Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Japan Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 29. India Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. India Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 31. South Korea Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 33. Australia Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Australia Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 37. Middle East and Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)
Table 39. UAE: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. UAE: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Saudi Arabia: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Saudi Arabia: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. South Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. South Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Rest of Middle East and Africa: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 47. South and Central America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 48. South and Central America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)
Table 49. Brazil: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 50. Brazil: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 51. Argentina: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 52. Argentina: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 53. Rest of South and Central America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 54. Rest of South and Central America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 1. Organic Developments in the Skin Cancer Diagnostic Market
Table 2. Inorganic Developments in the Skin Cancer Diagnostics Market
Table 3. Glossary of Terms, Skin Cancer Diagnostics Market
Table 4. Acronym